barriers to entry for the company products and therapies; Works closely with Health Economics and Outcome to evaluate the economic impact of the use of therapies/products on payers, including the government;
barriers to entry for the company products and therapies; Works closely with Health Economics and Outcome to evaluate the economic impact of the use of therapies/products on payers, including the government;